TNFAIP3 and breast carcinoma: A20 overexpressing MCF-7 breast cancer cells showed in comparison to wild-type MCF-7 cells an enhanced resistance towards the mitotic inhibitor taxol, while the cells showed no difference in response to gemcitabine-induced apoptosis induction [32].